| Dr Karlene R Ware, MD | |
|
10810 Connecticut Ave, Kensington, MD 20895-2138 | |
| (301) 929-7100 | |
| (301) 929-7114 |
| Full Name | Dr Karlene R Ware |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 10810 Connecticut Ave, Kensington, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396876645 | NPI | - | NPPES |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.
According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.
A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.
According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.
A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.
According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.
A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.
According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.
A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.
› Verified 3 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.
According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.
A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karlene R Ware, MD 2101 E Jefferson St, Kaiser Permanente, Ppqa, 6 West, Attn: Theresa Brooks, Rockville, MD 20852-4908 Ph: (301) 816-6660 | Dr Karlene R Ware, MD 10810 Connecticut Ave, Kensington, MD 20895-2138 Ph: (301) 929-7100 |
News Archive
Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.
Nearly eight months after a Napa State Hospital patient strangled a psychiatric technician, lawmakers and employee groups are pushing proposals aimed at reversing a worsening safety trend at California's mental health facilities.
According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.
A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.
› Verified 3 days ago
Ronjeet K Reddy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Janice Marie Bitetti, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7507 Fax: 301-929-7114 | |
Marya Sonny, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kaiser Permanente Kensington Medical Center, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Sawsan Said Hanna, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114 | |
Dr. Elizabeth Victoria Molyneaux, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114 | |
Yun Wang, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Chanda V Bell-lamarque, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: Kaiser Permanente, 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 |